Effects of perzinfotel on the minimum alveolar concentration of isoflurane in dogs

American Journal of Veterinary Research

Volumn 68, Issue 12, 2007, Pages 1294-1299

  Kushiro, Tokiko ^a,c   Wiese, Ashley J ^a,d   Eppler, Mark C ^b   Muir III, William W ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b ZOETIS   (United States)

^c WASHINGTON STATE UNIVERSITY   (United States)

^d MedVet   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN; ISOFLO; ISOFLURANE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR STIMULATING AGENT; OXYGEN; PERZINFOTEL; PROPOFOL; UNCLASSIFIED DRUG;

ANESTHETIC RECOVERY; ANIMAL EXPERIMENT; ARTERIAL PRESSURE; ARTICLE; BISPECTRAL INDEX; BLOOD PRESSURE MONITORING; BODY TEMPERATURE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DOG; DRUG DOSE COMPARISON; DRUG POTENTIATION; DRUG RESPONSE; HEART RATE; HEMODYNAMIC MONITORING; HEMOGLOBIN DETERMINATION; MALE; MEAN ARTERIAL PRESSURE; MINIMUM LUNG ALVEOLUS CONCENTRATION; NONHUMAN; OXYGEN SATURATION; SYSTOLIC BLOOD PRESSURE; TELEMETRY;

ANALGESICS; ANESTHESIA, INHALATION; ANESTHETICS, INHALATION; ANIMALS; AZABICYCLO COMPOUNDS; BLOOD PRESSURE; BODY TEMPERATURE; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; ISOFLURANE; MALE; PHOSPHONIC ACIDS; PULMONARY ALVEOLI;

ANIMALIA; CANIS FAMILIARIS;

EID: 37248999427     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.68.12.1294     Document Type: Article

References (29)

1. Muir WW III, Woolf CJ. Mechanisms of pain and their therapeutic implications. J Am Vet Med Assoc 2001;219:1346-1356.
2. Pozzi A, Muir WW III, Traverso F Prevention of central sensitization and pain by N-methyl-D-aspartate receptor antagonists. J Am Vet Med Assoc 2006;228:53-60.
3. Woolf CJ, Thompson SW. The induction and maintenance of central sensitization is dependent on N-methyl-D-aspartic acid receptor activation; implications for the treatment of post-injury pain hypersensitivity states. Pain 1991;44:293-299.
4. Petrenko AB, Yamakura T, Baba H, et al. The role Of N-methyl-D-aspartate (NMDA) receptors in pain: a review. Anesth Analg 2003; 97:1108-1116.
5. Mori H, Mishina M. Structure and function of the NMDA receptor channel. Neuropharmacology 1995;34:1219-1237.
6. Boyce S, Wyatt A, Webb JK, et al. Selective NMDA NR2B antagonists induce antinociception without motor dysfunction: correlation with restricted localization of NR2B subunit in dorsal horn. Neuropharmacology 1999;38:611-623.
7. Chazot PL. The NMDA receptor NR2B subunit: a valid therapeutic target for multiple CNS pathologies. Curr Med Chem 2004;11:389-396.
8. Sang CN. NMDA-receptor antagonists in neuropathic pain: experimental methods to clinical trials. J Pain Symptom Manage 2000;19:S21-S25.
9. Solano AM, Pypendop BH, Boscan PL, et al. Effect of intravenous administration of ketamine on the minimum alveolar concentration of isoflurane in anesthetized dogs. Am J Vet Res 2006;67:21-25.
10. Muir WW III, Wiese AJ, March PA. Effects of morphine, lidocaine, ketamine, and morphine-lidocaine-ketamine drug combination on minimum alveolar concentration in dogs anesthetized with isoflurane. Am J Vet Res 2003;64:1155-1160.
11. Lees P. The injectable anaesthetics. In: Brander GC, Pugh DM, Bywater RJ, et al, eds. Veterinary applied pharmacology & therapeutics. 5th ed. London: Bailliere Tindall, 1991;355-373.
12. Miki K, Zhou QQ, Guo W, et al. Changes in gene expression and neuronal phenotype in brain stem pain modulatory circuitry after inflammation. J Neurophysiol 2002;87:750-760.
13. Sun L, Chin D, Kowal D, et al. Characterization of two novel N-methyl-D-aspartate antagonists: EAA-090 (2-[8,9-dioxo-2,6-diazabicyclo[5.2.0]non-1(7)en2-yl]ethylphosphonic acid) and EAB-318(R-α-amino- 5-chloro-1 (phosphonomethyl)1H-benzimidazole-2-propanoic acid hydrochloride). J Pharmacol Exp Ther 2004;310:563-570.
14. Kinney WA, Abou-Gharbia M, Garrison DT, et al. Design and synthesis of [2(8,9-dioxo-2, 6-diazabicyclo [5.2.0] non-1(7)-en2- yl]ethylphosphonic acid (EAA090), a potent N-methyl-D-aspartate antagonist, via the use of 3-cyclobutene-1,2dione as an achiral alpha-animo acid bioisostere. J Med Chem 1998;41:236-246.
15. Liu H-T, Hollmann MW, Liu W-H, et al. Modulation of NMDA receptor function by ketamine and magnesium: part 1. Anesth Analg 2001;92:1173-1181.
16. Antognini JF, Carstens E. Measuring minimum alveolar concentration: more than meets the tail. Anesthesiology 2005;103:751-758.
17. Kissin I. Depth of anesthesia and bispectral index monitoring. Anesth Analg 2000;90:1114-1117.
18. Johansen JW, Sebel PS. Development and clinical application of electroencephalographic bispectrum monitoring. Anesthesiology 2000;93:1336-1344.
19. March PA, Muir WW III. Bispectral analysis of the electroencephalogram: a review of its development and use in anesthesia. Vet Anesth Analg 2005;32:241-255.
20. Hellyer PW, Mama KR, Shafford HL, et al. Effects of diazepam and flumazenil on minimum alveolar concentrations for dogs anesthetized with isoflurane or a combination of isoflurane and fentanyl. Am J Vet Res 2001;62:555-560.
21. Steffey EP, Howland D. Isoflurane potency in the dog and cat. Am J Vet Res 1977;38:1833-1836.
22. Kazma T, Ikeda K. Comparison of MAC and the rate of rise of alveolar concentration of sevoflurane with halothane and isoflurane in the dog. Anesthesiology 1988;68:435-438.
23. Antognini JF, Carstens E, Tabo E, et al. Effect of differential delivery of isoflurane to the head and torso on lumbar dorsal horn activity. Anesthesiology 1998;88:1055-1061.
24. Antognini JE Wang XW, Carstens E. Quantitative and qualitative effects of isoffurane on movement occurring after noxious stimulation. Anesthesiology 1999;91:1064-1071.
25. Dutton RC, Zhang Y, Stabernack CR, et al. Temporal summation governs part of the minimum alveolar concentration of isoflurane anesthesia. Anesthesiology 2003;98:1372-1377.
26. Baranauskas G, Nistri A. Sensitization of pain pathways in the spinal cord: cellular mechanisms. Prog Neurobiol 1998;54:349-365.
27. Tweed WA, Minuck MS, Mymin D. Circulatory response to ketamine anesthesia. Anesthesiology 1972;37:613-619.
28. Stoelting RK, Hillier SC. Nonbarbiturate intravenous anesthetic drugs. In: Stoelting RK, Hillier SC, eds. Pharmacology & physiology in anesthetic practice. 4th ed. Philadelphia: Lippincott Williams & Wilkins, 2006;155-178.
29. Boscan P, Pypendop BH, Solano AM, et al. Cardiovascular and respiratory effects of ketamine infusions in isoflurane-anesthetized dogs before and during noxious stimulation. Am J Vet Res 2005;66:2122-2129.